VAERS reports by lot

GSK Hepatitis A lot 95EJ7: VAERS reports

29 VAERS reports list lot 95EJ7 as a GSK Hepatitis A vaccine, received between 2022-02-12 and 2023-08-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological431%
General / Systemic (non-local)215%
Injection-site / Local reaction215%
Cardiac / Cardiovascular18%
Allergic / Anaphylactic18%
Gastrointestinal18%
Musculoskeletal18%
Psychiatric / Neuropsychiatric18%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
Kentucky4
California3
Michigan2
Georgia2
Colorado1
Alabama1
Oregon1
Wisconsin1
Ohio1
Iowa1
New York1

Reports by month received

2022-022
2022-037
2022-043
2022-054
2022-062
2022-082
2022-092
2022-102
2022-111
2023-021
2023-041
2023-061
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.